NICE Yervoy, Invokana Rulings Show Need for Regulator/HTA Dialogue
This article was originally published in The Pink Sheet Daily
Executive Summary
NICE downgrades BMS’ Yervoy, while Janssen omits filing for all combinations for Invokana, underscoring the need for EU harmonization through HTA/regulator dialogue.